Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 121

1.

Kinetic and Thermodynamic Evaluation of Kynurenic Acid Binding to GluR1270-300 Polypeptide by Surface Plasmon Resonance Experiments.

Juhász Á, Csapó E, Ungor D, Tóth GK, Vécsei L, Dékány I.

J Phys Chem B. 2016 Aug 18;120(32):7844-50. doi: 10.1021/acs.jpcb.6b05682. Epub 2016 Aug 8.

PMID:
27459050
2.

No association of GRIA1 polymorphisms with schizophrenia in the Chinese Han population.

Niu W, Huang X, Yu T, Chen S, Li X, Wu X, Cao Y, Zhang R, Bi Y, Yang F, Wang L, Li W, Xu Y, He L, He G.

Psychiatr Genet. 2016 Apr;26(2):97-8. doi: 10.1097/YPG.0000000000000117. No abstract available.

PMID:
26862833
3.

Case-control study of GRIA1 and GRIA3 gene variants in migraine.

Fang J, An X, Chen S, Yu Z, Ma Q, Qu H.

J Headache Pain. 2015;17:2. doi: 10.1186/s10194-016-0592-2. Epub 2016 Jan 22.

4.

Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.

Rajić V, Debeljak M, Goričar K, Jazbec J.

Leuk Lymphoma. 2015;56(11):3103-8. doi: 10.3109/10428194.2015.1020802. Epub 2015 Mar 30.

PMID:
25697915
5.

Regulation of GluA1 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor function by protein kinase C at serine-818 and threonine-840.

Jenkins MA, Wells G, Bachman J, Snyder JP, Jenkins A, Huganir RL, Oswald RE, Traynelis SF.

Mol Pharmacol. 2014 Apr;85(4):618-29. doi: 10.1124/mol.113.091488. Epub 2014 Jan 22.

6.

Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans.

Cargnin S, Viana M, Mittino D, Bellomo G, Tassorelli C, Nappi G, Canonico PL, Terrazzino S.

Neurol Sci. 2014 Mar;35(3):421-7. doi: 10.1007/s10072-013-1535-1. Epub 2013 Sep 13.

PMID:
24030684
7.

Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.

Oh MC, Kim JM, Safaee M, Kaur G, Sun MZ, Kaur R, Celli A, Mauro TM, Parsa AT.

PLoS One. 2012;7(10):e47846. doi: 10.1371/journal.pone.0047846. Epub 2012 Oct 23.

8.

Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population.

Kang WS, Park JK, Kim SK, Park HJ, Lee SM, Song JY, Chung JH, Kim JW.

Mol Biol Rep. 2012 Dec;39(12):10697-703. doi: 10.1007/s11033-012-1960-x. Epub 2012 Oct 8.

PMID:
23053966
9.

Not all desensitizations are created equal: physiological evidence that AMPA receptor desensitization differs for kainate and glutamate.

Levchenko-Lambert Y, Turetsky DM, Patneau DK.

J Neurosci. 2011 Jun 22;31(25):9359-67. doi: 10.1523/JNEUROSCI.6761-10.2011.

10.

Ligand-binding domain determines endoplasmic reticulum exit of AMPA receptors.

Coleman SK, Möykkynen T, Hinkkuri S, Vaahtera L, Korpi ER, Pentikäinen OT, Keinänen K.

J Biol Chem. 2010 Nov 12;285(46):36032-9. doi: 10.1074/jbc.M110.156943. Epub 2010 Sep 13.

11.

Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, Evans WE, Pui CH, Relling MV.

Clin Pharmacol Ther. 2010 Aug;88(2):191-6. doi: 10.1038/clpt.2010.94. Epub 2010 Jun 30. Erratum in: Clin Pharmacol Ther. 2014 Nov;96(5):625. Clin Pharmacol Ther. 2014 Nov;96(5):625.

12.

Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment.

van Vuurden DG, Yazdani M, Bosma I, Broekhuizen AJ, Postma TJ, Heimans JJ, van der Valk P, Aronica E, Tannous BA, Würdinger T, Kaspers GJ, Cloos J.

PLoS One. 2009 Jun 18;4(6):e5953. doi: 10.1371/journal.pone.0005953.

13.

Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder.

Kerner B, Jasinska AJ, DeYoung J, Almonte M, Choi OW, Freimer NB.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):24-32. doi: 10.1002/ajmg.b.30780.

14.

Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation.

de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK.

J Neurooncol. 2008 Jun;88(2):121-33. doi: 10.1007/s11060-008-9552-2.

PMID:
18317690
15.

Receptor occupancy and channel-opening kinetics: a study of GLUR1 L497Y AMPA receptor.

Pei W, Ritz M, McCarthy M, Huang Z, Niu L.

J Biol Chem. 2007 Aug 3;282(31):22731-6. Epub 2007 Jun 1.

16.

Targeting AMPA receptor gating processes with allosteric modulators and mutations.

Mitchell NA, Fleck MW.

Biophys J. 2007 Apr 1;92(7):2392-402. Epub 2007 Jan 5.

17.

Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample.

Magri C, Gardella R, Barlati SD, Podavini D, Iatropoulos P, Bonomi S, Valsecchi P, Sacchetti E, Barlati S.

Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):287-93.

PMID:
16526023
18.

C-terminal truncation affects kinetic properties of GluR1 receptors.

Suzuki E, Kessler M, Arai AC.

Mol Cell Neurosci. 2005 May;29(1):1-10.

PMID:
15866042
19.

How fast does the GluR1Qflip channel open?

Li G, Niu L.

J Biol Chem. 2004 Feb 6;279(6):3990-7. Epub 2003 Nov 10.

20.

Modeling of the pore domain of the GLUR1 channel: homology with K+ channel and binding of channel blockers.

Tikhonov DB, Mellor JR, Usherwood PN, Magazanik LG.

Biophys J. 2002 Apr;82(4):1884-93.

Supplemental Content

Support Center